A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects

Trial Identifier:	TDU16639
Sponsor:	Sanofi
NCTID::	NCT05846009
Start Date:	November 2020
Study Completion Date:	July 2021
Condition:	Osteochondrodysplasia; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States	United States

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.